Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease

Pediatric Blood and Cancer

Volumn 64, Issue 11, 2017, Pages

  Woods, Deborah ^a   Hayashi, Robert J ^a   Binkley, Michael M ^a   Sparks, Gianna W ^b   Hulbert, Monica L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

central venous catheter; iron overload; red blood cell transfusion; sickle cell anemia; stroke

Indexed keywords

FERRITIN; HEMOGLOBIN S;

ADOLESCENT; ADULT; APHERESIS; ARTICLE; BETA THALASSEMIA; CATHETER COMPLICATION; CATHETER INFECTION; CATHETER MIGRATION; CENTRAL VENOUS CATHETER; CHELATION THERAPY; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ERYTHROCYTAPHERESIS; EXCHANGE BLOOD TRANSFUSION; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; MALE; PHLEBOTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SICKLE CELL ANEMIA; STENOSIS; TREATMENT DURATION; ANEMIA, SICKLE CELL; CLINICAL TRIAL; COMPLICATION; ERYTHROCYTE TRANSFUSION; FOLLOW UP; IRON OVERLOAD; METABOLISM; PRESCHOOL CHILD; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; ERYTHROCYTE TRANSFUSION; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN, SICKLE; HUMANS; IRON OVERLOAD; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 85019545909     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.26635     Document Type: Article

References (28)

1. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288–294.
2. Russell MO, Goldberg HI, Hodson A, et al. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood. 1984;63(1):162–169.
3. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. New Engl J Med. 1998;339(1):5–11.
4. Ware RE, Helms RW. Stroke with transfusions changing to hydroxyurea (SWiTCH). Blood. 2012;119(17):3925–3932.
5. Kelly S, Quirolo K, Marsh A, et al. Erythrocytapheresis for chronic transfusion therapy in sickle cell disease: survey of current practices and review of the literature. Transfusion. 2016;56(11):2877–2888.
6. Fasano RM, Leong T, Kaushal M, et al. Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients. Transfusion. 2016;56(7):1707–1715.
7. Jeng MR, Feusner J, Skibola C, et al. Central venous catheter complications in sickle cell disease. Am J Hematol. 2002;69(2):103–108.
8. Shah N, Landi D, Shah R, et al. Complications of implantable venous access devices in patients with sickle cell disease. Am J Hematol. 2012;87(2):224–226.
9. Alkindi S, Matwani S, Al-Maawali A, et al. Complications of PORT-A-CATH(R) in patients with sickle cell disease. J Infect Publ Health. 2012;5(1):57–62.
10. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381.
11. Andersen PK, Gill RD. Cox regression-model for counting-processes—a large sample study. Ann Stat. 1982;10(4):1100–1120.
12. Naik RP, Streiff MB, Haywood C, Jr., et al. Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease. J Thromb Haemost. 2014;12(12):2010–2016.
13. Evans RS, Sharp JH, Linford LH, et al. Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest. 2010;138(4):803–810.
14. Evans RS, Sharp JH, Linford LH, et al. Reduction of peripherally inserted central catheter-associated DVT. Chest. 2013;143(3):627–633.
15. Steinberg MH. More blood for sickle cell anemia? New Engl J Med. 2014;371(8):775–776.
16. Fields JM, Piela NE, Au AK, et al. Risk factors associated with difficult venous access in adult ED patients. Am J Emerg Med. 2014;32(10):1179–1182.
17. Shrestha A, Jawa Z, Koch KL, et al. Use of a dual lumen port for automated red cell exchange in adults with sickle cell disease. J Clin Apheresis. 2015;30(6):353–358.
18. Batacchi S, Zagli G, Braccini G, et al. Totally implantable vascular access devices in adult patients for cystic fibrosis management. Am J Respir Crit Care Med. 2011;183(1):133–134; author reply 134.
19. Aitken ML, Tonelli MR. Complications of indwelling catheters in cystic fibrosis: a 10-year review. Chest. 2000;118(6):1598–1602.
20. Dal Molin A, Di Massimo DS, Braggion C, et al. Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study. J Vasc Access. 2012;13(3):290–295.
21. Vichinsky EP, Ohene-Frempong K, Thein SL, et al. Transfusion and chelation practices in sickle cell disease: a regional perspective. J Pediatr Hematol Oncol. 2011;28(2):124–133.
22. Duclos C, Merlin E, Paillard C, et al. Long-term red blood cell exchange in children with sickle cell disease: manual or automatic? Transfus Apher Sci. 2013;48(2):219–222.
23. Koehl B, Sommet J, Holvoet L, et al. Comparison of automated erythrocytapheresis versus manual exchange transfusion to treat cerebral macrovasculopathy in sickle cell anemia. Transfusion. 2016;56(5):1121–1128.
24. Savage WJ, Reddoch S, Wolfe J, et al. Partial manual exchange reduces iron accumulation during chronic red cell transfusions for sickle cell disease. J Pediatr Hematol Oncol. 2013;35(6):434–436.
25. Aloni MN, Le PQ, Heijmans C, et al. A pilot study of manual chronic partial exchange transfusion in children with sickle disease. Hematology. 2015;20(5):284–288.
26. Stanley HM, Friedman DF, Webb J, et al. Transfusional iron overload in a cohort of children with sickle cell disease: impact of magnetic resonance imaging, transfusion method, and chelation. Pediatr Blood Cancer. 2016;63(8):1414–1418.
27. Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood. 2005;106(4):1460–1465.
28. Puliyel M, Sposto R, Berdoukas VA, et al. Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload. Am J Hematol. 2014;89(4):391–394.